LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.59 | 21.74 | 2451 | 4492 | 0.5456 | 0.8485 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.59 | 21.74 | 3647 | 4492 | 0.8119 | 0.9465 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.56 | 21.74 | 252 | 4838 | 0.0521 | 0.3692 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.56 | 21.74 | 3942 | 4838 | 0.8147 | 0.9481 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.56 | 21.74 | 2786 | 4838 | 0.5758 | 0.8633 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.56 | 21.74 | 3953 | 4838 | 0.8169 | 0.9488 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.53 | 21.74 | 321 | 5150 | 0.0623 | 0.4068 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.53 | 21.74 | 4243 | 5150 | 0.8238 | 0.9514 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.53 | 21.74 | 3032 | 5150 | 0.5887 | 0.8701 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.53 | 21.74 | 4244 | 5150 | 0.8240 | 0.9515 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.50 | 21.74 | 320 | 5425 | 0.0590 | 0.4017 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.50 | 21.74 | 4475 | 5425 | 0.8248 | 0.9522 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.50 | 21.74 | 3129 | 5425 | 0.5767 | 0.8664 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.50 | 21.74 | 4599 | 5425 | 0.8476 | 0.9589 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.48 | 21.74 | 394 | 5768 | 0.0683 | 0.4331 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.48 | 21.74 | 4795 | 5768 | 0.8312 | 0.9546 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.48 | 21.74 | 2931 | 5768 | 0.5081 | 0.8387 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.48 | 21.74 | 4915 | 5768 | 0.8520 | 0.9606 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.45 | 21.74 | 391 | 6023 | 0.0649 | 0.4278 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.45 | 21.74 | 5135 | 6023 | 0.8525 | 0.9611 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.45 | 21.74 | 3126 | 6023 | 0.5190 | 0.8447 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 57.45 | 21.74 | 5219 | 6023 | 0.8664 | 0.9650 | MN20160310_N01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.42 | 21.74 | 453 | 6125 | 0.0740 | 0.4523 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.42 | 21.74 | 5523 | 6125 | 0.9017 | 0.9747 | MN20160310_N01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.42 | 21.74 | 3249 | 6125 | 0.5304 | 0.8501 | MN20160310_N01 | E11 |